Metadata Sub-indicator 3.b.1.5. Proportion of vaccinated population against human papilomavirus

Goal 3. Ensure healthy lives and promote well-being for all at all ages

Target 3.b. Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.

Indicator 3.b.1. Proportion of the target population covered by all vaccines included in their national programme

Sub-indicator 3.b.1.5. Proportion of vaccinated population against human papilomavirus

• Global

Percentage of boys and girls, of a certain cohort, vaccinated with at least one doses of vaccine against the human papillomavirus.

\[ PV_{papiloma}^{cohorte}=\frac{ V_{papiloma}^{cohorte}}{P^{cohorte}} \cdot 100 \]Where: \( V_{papiloma}^{cohorte}\)is the number of people in the established cohorts who have received at least one doses of vaccine against the human papillomavirus and \( P^{cohorte}\)is the number of people born in the established years of that cohort.

Percentage

Annual

AC Sex

Tier I

No

Systematic Vaccination Statistics (ISO code: 54022)

MSND together with Consejerías/departamentos con competencia en la materia de las comunidades autónomas

11/02/2026

WHO, UNICEF